We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Siemens Healthineers Launches Thermocycler with AI-Powered Software

By LabMedica International staff writers
Posted on 26 Apr 2018
Siemens Healthineers (Erlangen, Germany) launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). More...
The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation.

Weighing two kilograms and measuring 150 mm x 150 mm x 130 mm, the FTC is a scalable platform, allowing up to 10 thermocyclers to be connected to one computer and permitting laboratories to utilize a range of 1 to 480 wells. The FTC uses magnetic induction technology to deliver robust and reliable results, and does not require calibration, as a result of which it does not drift or age and offers simple handling. The FTC is also equipped with the Fast Track lyophilised technology, offering reagents for PCR experiments in a single sample tube, simplifying processes for users by eliminating the need to prepare the reaction mix before test implementation. The technology allows users to simply add nucleic acid extracts to the prepared tubes before inserting into the cycler.

Siemens Healthineers, in collaboration with UgenTec, also launched FastFinder software, which is a fully automated real-time PCR interpretation platform that is compatible with all multiplexing kits from Fast Track Diagnostics. The software allows users to fully automate and standardize analysis of kits with the Applied Biosystems 7500 and LightCycler 480 PCR platforms. FastFinder uses its built-in statistical machine learning models to accurately analyze every amplification curve, then automatically combines these results and processes them through an assay-specific decision tree, leading to overall and conclusive results.

With automated plate detection, Laboratory Information Management System (LIMS) connection, and a user-friendly interface, FastFinder is easy-to-use and requires limited training. All assay parameters come pre-set for speed and ease of implementation, and clear, customizable reports allow easy reading of results. The audit trail of analysis, integrated archive, and simultaneous analysis of multiple run files results in improved monitoring and enables users to provide patients with the relevant treatment more quickly.

“Enabled by AI, FastFinder software minimizes the need for manual processing, which not only saves time, but increases the reliability of results as well,” said Fernando Beils, Head of Molecular Diagnostics, Siemens Healthineers. “Users receive 100% reproducible results in a matter of seconds, improving laboratory workflows and expanding precision medicine."

"Siemens Healthineers' focus on AI aligns perfectly with our vision for FastFinder. The combination of Siemens Healthineers' hardware and assays and our extensible software will guide laboratories globally to simple, accurate, and automated molecular diagnostics," said Steven Verhoeven, CEO at UgenTec.


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Serological Pipet Controller
PIPETBOY GENIUS
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
New
Shaking Incubator
Corning LSE 71L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: Cord blood proteomics can identify biomarkers of early-onset neonatal sepsis (Photo courtesy of JCI Insight (2025). DOI: 10.1172/jci.insight.193826)

Umbilical Cord Blood Test Can Detect Early Sepsis in Preterm Infants

Diagnosing early onset sepsis (EOS) in preterm infants is particularly difficult due to the lack of specific clinical signs, leading to widespread use of antibiotics while awaiting culture results.... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: NGS can detect one tumor cell among a million healthy cells from a simple blood sample (Photo courtesy of Shutterstock)

New Tool Detects Breast Cancer Relapses Five Years in Advance

Relapse detection in patients with solid tumors—particularly hormone receptor-positive (HR+) breast cancer—remains a major clinical challenge, as many patients initially respond well to treatment but later... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.